Nevro Acquires Vyrsa

Started by drusso
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

drusso

Full Member
Moderator Emeritus
Lifetime Donor
Advertisement - Members don't see this ad
I can't wait for the debrief on this at NANS...together, we are stronger.


1701455010230.png
 
I can't wait for the debrief on this at NANS...together, we are stronger.


View attachment 379343


Do you mean to put that In magenta?

Nevro manipulated their data and is way less effective than they claimed.

Vyrsa pushes SIJ fusions which is wrong for the patient 98% of the time.
 
Advertisement - Members don't see this ad
Recent ASRA abstract, post implant:

The study population comprised of 237 patients , of which 67.51% were responders and 32.49% were
nonresponders.
 

Attachments

  • Screenshot_20231201-174342.png
    Screenshot_20231201-174342.png
    483.7 KB · Views: 183
Looks like they just analyzed all patients in a date range? I don’t see anything about the underlying diagnoses. I bet a bunch of those were implanted for axial LBP. Sayed is a big Nevro KOL.
Looks so. Underlying diagnosis seems to be narrowed down to lumbar based on intro, not sure if FBSS vs virgin/axial backs. My take away is 1/3 fail rate is not good.
 
Advertisement - Members don't see this ad
Recent ASRA abstract, post implant:

The study population comprised of 237 patients , of which 67.51% were responders and 32.49% were
nonresponders.
Here is the Abbott version.
 
Advertisement - Members don't see this ad
Do you mean to put that In magenta?

Nevro manipulated their data and is way less effective than they claimed.

Vyrsa pushes SIJ fusions which is wrong for the patient 98% of the time.
manipulated how?
Isnt SENZA one of the very few Level 1 RCTs we have in the pain world for neuromod?